| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 944 |
| 1 | ASPIRIN | 833 |
| 2 | ASPIRIN 325 MG | 794 |
| 3 | ASPIRIN 81 MG | 794 |
| 4 | RANOLAZINE | 582 |
| 5 | ATORVASTATIN CALCIUM | 418 |
| 6 | METOPROLOL TARTRATE | 358 |
| 7 | FUROSEMIDE | 320 |
| 8 | LISINOPRIL | 309 |
| 9 | METOPROLOL | 309 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANOLAZINE | 582 | 0.0552 |
| 1 | GUAIFENESIN AND CODEINE PHOSPHATE | 2 | 0.0150 |
| 2 | GOLD | 53 | 0.0091 |
| 3 | PRASUGREL HYDROCHLORIDE | 84 | 0.0083 |
| 4 | LANOLIN, PETROLATUM | 2 | 0.0081 |
| 5 | LANOLIN AND PETROLATUM | 2 | 0.0076 |
| 6 | PHENAZOPYRIDINE HYDROCHLORIDE | 2 | 0.0061 |
| 7 | MINOCYCLINE HYDROCHLORIDE | 33 | 0.0056 |
| 8 | CANAKINUMAB | 60 | 0.0055 |
| 9 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 2 | 0.0054 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1006 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 843 |
| 2 | Anti-anginal [EPC] | 582 |
| 3 | Corticosteroid [EPC] | 419 |
| 4 | Insulin Analog [EPC] | 417 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 407 |
| 6 | Loop Diuretic [EPC] | 361 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 361 |
| 8 | beta-Adrenergic Blocker [EPC] | 340 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 273 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-anginal [EPC] | 582 | 0.0552 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 61 | 0.0036 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 361 | 0.0030 |
| 3 | Methylating Agent [EPC] | 3 | 0.0029 |
| 4 | PCSK9 Inhibitor [EPC] | 70 | 0.0027 |
| 5 | Nitrate Vasodilator [EPC] | 234 | 0.0026 |
| 6 | Melanin Synthesis Inhibitor [EPC] | 3 | 0.0026 |
| 7 | Uric Acid-specific Enzyme [EPC] | 9 | 0.0023 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 10 | 0.0023 |
| 9 | Dietary Cholesterol Absorption Inhibitor [EPC] | 175 | 0.0019 |